211 related articles for article (PubMed ID: 12570838)
21. Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1.
Arellano Y; Bratoeff E; Heuze Y; Bravo M; Soriano J; Cabeza M
Bioorg Med Chem; 2018 Aug; 26(14):4058-4064. PubMed ID: 30007568
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
[TBL] [Abstract][Full Text] [Related]
23. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
[TBL] [Abstract][Full Text] [Related]
24. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
25. A new label-free screen for steroid 5α-reductase inhibitors using LC-MS.
Srivilai J; Rabgay K; Khorana N; Waranuch N; Nuengchamnong N; Ingkaninan K
Steroids; 2016 Dec; 116():67-75. PubMed ID: 27789379
[TBL] [Abstract][Full Text] [Related]
26. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.
Pais P
Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347
[TBL] [Abstract][Full Text] [Related]
27. 5alpha-reductase activity in the prostate.
Steers WD
Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
[TBL] [Abstract][Full Text] [Related]
28. Steroidal 5α-reductase inhibitors using 4-androstenedione as substrate.
Cabeza M; Trejo KV; González C; García P; Soriano J; Heuze Y; Bratoeff E
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):712-9. PubMed ID: 21299452
[TBL] [Abstract][Full Text] [Related]
29. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.
Garrido M; Bratoeff E; Bonilla D; Soriano J; Heuze Y; Cabeza M
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):367-73. PubMed ID: 21782943
[TBL] [Abstract][Full Text] [Related]
30. 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():164-5. PubMed ID: 12434569
[TBL] [Abstract][Full Text] [Related]
31. CGP 53153: a new potent inhibitor of 5alpha-reductase.
Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
[TBL] [Abstract][Full Text] [Related]
32. Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
Bratoeff EA; Herrera H; Ramírez E; Solorzano K; Murillo E; Quiróz A; Cabeza M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1249-55. PubMed ID: 10993221
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols.
Hiipakka RA; Zhang HZ; Dai W; Dai Q; Liao S
Biochem Pharmacol; 2002 Mar; 63(6):1165-76. PubMed ID: 11931850
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of Serenoa repens on the kinetic of pig prostatic microsomal 5alpha-reductase activity.
Palin MF; Faguy M; LeHoux JG; Pelletier G
Endocrine; 1998 Aug; 9(1):65-9. PubMed ID: 9798732
[TBL] [Abstract][Full Text] [Related]
36. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
37. Role of 5α-reductase inhibitors in benign prostatic diseases.
Azzouni F; Mohler J
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
[TBL] [Abstract][Full Text] [Related]
38. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia.
Sun J; Xiang H; Yang LL; Chen JB
Curr Med Chem; 2011; 18(23):3576-89. PubMed ID: 21756226
[TBL] [Abstract][Full Text] [Related]
39. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Study of Some 17a-aza-D-homo Steroids as 5α-Reductase Inhibitors.
Rana P; Dhingra N; Arora P; Dhingra R; Monika C; Gupta A
Curr Drug Discov Technol; 2021; 18(5):e22092020186180. PubMed ID: 32962621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
